Discovery and structural characterization of a small molecule 14-3-3 protein-protein interaction inhibitor
Open accessAbstract
The 14-3-3 family of phosphoserine/threonine-recognition proteins engage multiple nodes in signaling networks that control diverse physiological and pathophysiological functions and have emerged as promising therapeutic targets for such diseases as cancer and neurodegenerative disorders. Thus, small molecule modulators of 14-3-3 are much needed agents for chemical biology investigations and therapeutic development. To analyze 14-3-3 function and modulate its activity, we conducted a chemical screen and identified 4-[(2Z)-2-[4-formyl-6-methyl-5-oxo-3-(phosphonatooxymethyl)pyridin-2-ylidene]hydrazinyl]benzoate as a 14-3-3 inhibitor, which we termed FOBISIN (FOurteen-three-three BInding Small molecule INhibitor) 101. FOBISIN101 effectively blocked the binding of 14-3-3 with Raf-1 and proline-rich AKT substrate, 40 kD a and neutralized the ability of 14-3-3 to activate exoenzyme S ADP-ribosyltransferase. To provide a mechanistic basis for 14-3-3 inhibition, the crystal structure of 14-3-3 ζ in complex with FOBISIN101 was solved. Unexpectedly, the double bond linking the pyridoxal-phosphate and benzoate moieties was reduced by X-rays to create a covalent linkage of the pyridoxal-phosphate moiety to lysine 120 in the binding groove of 14-3-3, leading to persistent 14-3-3 inactivation. We suggest that FOBISIN101-like molecules could be developed as an entirely unique class of 14-3-3 inhibitors, which may serve as radiation-triggered therapeutic agents for the treatment of 14-3-3-mediated diseases, such as cancer.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
<i>Coot</i> : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571 · see citing works
Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination
Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse‐Kunstleve, R. W., Jiang, J., Kuszewski, J. J., Nilges, M., Pannu, N., et al. (1998) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444998003254 · Cited by 15,720 · see citing works
Jones, T. A., Zou, J.-Y., Cowan, S. W., & Kjeldgaard, M. (1991) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767390010224 · Cited by 12,650 · see citing works
PRODRG: a tool for high-throughput crystallography of protein–ligand complexes
Schüttelkopf, A. W., & van Aalten, D. M. F. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904011679 · Cited by 4,815 · see citing works
The Structural Basis for 14-3-3:Phosphopeptide Binding Specificity
Yaffe, M. B., Rittinger, K., Volinia, S., Caron, P. R., Aitken, A., Leffers, H. C. B., Gamblin, S. J., Smerdon, S. J., & Cantley, L. C. (1997) · Cell · doi:10.1016/s0092-8674(00)80487-0 · Cited by 1,604 · see citing works
14-3-3 Proteins: Structure, Function, and Regulation
Fu, H., Subramanian, R. R., & Masters, S. C. (2000) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.617 · Cited by 1,569 · see citing works
Self-citationInteraction of 14-3-3 with Signaling Proteins Is Mediated by the Recognition of Phosphoserine
Muslin, A. J., Tanner, J. W., Allen, P. M., & Shaw, A. S. (1996) · Cell · doi:10.1016/s0092-8674(00)81067-3 · Cited by 1,380 · see citing works
Likelihood-enhanced fast rotation functions
Storoni, L. C., McCoy, A. J., & Read, R. J. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444903028956 · Cited by 1,177 · see citing works
14-3-3 proteins: A historic overview
Aitken, A. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.03.005 · Cited by 829 · see citing works
Crystal structure of the zeta isoform of the 14-3-3 protein
Liu, D., Bienkowska, J. R., Petosa, C., Collier, R. J., Fu, H., & Liddington, R. (1995) · Nature · doi:10.1038/376191a0 · Cited by 526 · see citing works
Self-citationDougherty, M. K., & Morrison, D. K. (2004) · Journal of Cell Science · doi:10.1242/jcs.01171 · Cited by 457 · see citing works
Jin, J., Smith, F. D., Stark, C., Wells, C. D., Fawcett, J. P., Kulkarni, S., Metalnikov, P. S., O’Donnell, P. A., Taylor, P., Taylor, L., et al. (2004) · Current Biology · doi:10.1016/j.cub.2004.07.051 · Cited by 448 · see citing works
RUBIO, M. P., Geraghty, K. M., WONG, B. H. C., Wood, N. T., Campbell, D. G., MORRICE, N. A., & MacKintosh, C. (2004) · Biochemical Journal · doi:10.1042/bj20031797 · Cited by 443 · see citing works
Zippo, A., Serafini, R., Rocchigiani, M., Pennacchini, S., Křepelová, A., & Oliviero, S. (2009) · Cell · doi:10.1016/j.cell.2009.07.031 · Cited by 418 · see citing works
Structural basis for protein–protein interactions in the 14-3-3 protein family
Yang, X., Lee, W. H., Sobott, F., Papagrigoriou, E., Robinson, C. V., Grossmann, J. G., Sundström, M., Doyle, D., & Elkins, J. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605779103 · Cited by 415 · see citing works
Crystal Structure of the 14-3-3ζ:Serotonin N-Acetyltransferase Complex
Obšil, T., Ghirlando, R., Klein, D. C., Ganguly, S., & Dyda, F. (2001) · Cell · doi:10.1016/s0092-8674(01)00316-6 · Cited by 389 · see citing works
Activation of Raf-1 by 14-3-3 proteins
Fantl, W. J., Muslin, A. J., Kikuchi, A., Martin, J. A., MacNicol, A. M., Grosst, R. W., & Williams, L. T. (1994) · Nature · doi:10.1038/371612a0 · Cited by 367 · see citing works
Petosa, C., Masters, S. C., Bankston, L. A., Pohl, J., Wang, B., Fu, H., & Liddington, R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.26.16305 · Cited by 345 · see citing works
Self-citation14-3-3 Proteins Mediate an Essential Anti-apoptotic Signal
Masters, S. C., & Fu, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105971200 · Cited by 319 · see citing works
Self-citationPhosphopeptide Analysis by Matrix-Assisted Laser Desorption Time-of-Flight Mass Spectrometry
Annan, R. S., & Carr, S. A. (1996) · Analytical Chemistry · doi:10.1021/ac960221g · Cited by 310 · see citing works
Isolation of High-Affinity Peptide Antagonists of 14-3-3 Proteins by Phage Display
Wang, B., Yang, H., Liu, Y., Jelı́nek, T., Zhang, L., Ruoslahti, E. I., & Fu, H. (1999) · Biochemistry · doi:10.1021/bi991353h · Cited by 304 · see citing works
Self-citationStimulatory Effects of Yeast and Mammalian 14-3-3 Proteins on the Raf Protein Kinase
Irie, K., Gotoh, Y., Yashar, B. M., Errede, B., Nishida, E., & Matsumoto, K. (1994) · Science · doi:10.1126/science.8085159 · Cited by 294 · see citing works
Interaction of the Protein Kinase Raf-1 with 14-3-3 Proteins
Fu, H., Xia, K., Pallas, D. C., Cui, C., Conroy, K. B., Narsimhan, R. P., Mamon, H. J., Collier, R. J., & Roberts, T. M. (1994) · Science · doi:10.1126/science.7939632 · Cited by 292 · see citing works
Self-citationMolecular basis for the recognition of phosphorylated and phosphoacetylated histone h3 by 14-3-3.
Macdonald, N., Welburn, J., Noble, M., Nguyen, A., Yaffe, M., Clynes, D., Moggs, J., Orphanides, G., Thomson, S., Edmunds, J. W., et al. (2005) · Molecules and Cells · doi:10.1016/j.molcel.2005.08.032 · Cited by 282 · see citing works
Fu, H., Coburn, J., & Collier, R. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.6.2320 · Cited by 267 · see citing works
Self-citationNeubauer, G., & Mann, M. (1998) · Analytical Chemistry · doi:10.1021/ac9804902 · Cited by 233 · see citing works
Ganguly, S., Weller, J. L., Ho, A., Chemineau, P., Malpaux, B., & Klein, D. C. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406871102 · Cited by 220 · see citing works
Michaud, N. R., Fabian, J. R., Mathes, K. D., & Morrison, D. K. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3390 · Cited by 213 · see citing works
Comprehensive Proteomic Analysis of Interphase and Mitotic 14-3-3-binding Proteins
Meek, S. E. M., Lane, W. S., & Piwnica-Worms, H. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403044200 · Cited by 211 · see citing works
C‐terminal binding: An expanded repertoire and function of 14‐3‐3 proteins
Coblitz, B., Wu, M., Shikano, S., & Li, M. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.02.014 · Cited by 170 · see citing works
Self-citationOttmann, C., Yasmin, L., Weyand, M., Veesenmeyer, J. L., Diaz, M. H., Palmer, R. H., Francis, M. S., Hauser, A. R., Wittinghofer, A., & Hallberg, B. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601530 · Cited by 164 · see citing works
Functional Conservation of 14-3-3 Isoforms in Inhibiting Bad-Induced Apoptosis
Subramanian, R. R., Masters, S. C., Zhang, H., & Fu, H. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5376 · Cited by 104 · see citing works
Self-citationFunctional domains of Pseudomonas aeruginosa exoenzyme S
Knight, D. A., Finck‐Barbançon, V., Kulich, S. M., & Barbieri, J. T. (1995) · Infection and Immunity · doi:10.1128/iai.63.8.3182-3186.1995 · Cited by 74 · see citing works
Self-citationMonitoring 14-3-3 Protein Interactions with a Homogeneous Fluorescence Polarization Assay
Du, Y., Masters, S. C., Khuri, F. R., & Fu, H. (2006) · SLAS DISCOVERY · doi:10.1177/1087057105284862 · Cited by 37 · see citing works
Self-citationKinumi, T., Niwa, H., & Matsumoto, H. (2000) · Analytical Biochemistry · doi:10.1006/abio.1999.4376 · Cited by 30 · see citing works
Photolysis of an asymmetrically substituted diazene in solution and in the crystalline state
Hoijemberg, P. A., Karlen, S. D., Sanramé, C. N., Aramendía, P. F., & Garcı́a-Garibay, M. A. (2009) · Photochemical & Photobiological Sciences · doi:10.1039/b902272d · Cited by 11 · see citing works
Jagannadham, M. V., & Nagaraj, R. (2008) · Analytical Chemistry Insights · doi:10.4137/aci.s497 · Cited by 10 · see citing works
Antiamnesic activity of the nicotinic agonist DBO-83 in mice
Ghelardini, C., Galeotti, N., Giuliani, F., Barlocco, D., & Bartolini, A. (1998) · Drug Development Research · doi:10.1002/(sici)1098-2299(199810)45:2 · Cited by 2 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Modulators of Protein–Protein Interactions
Milroy, L.-G., Grossmann, T. N., Hennig, S., Brunsveld, L., & Ottmann, C. (2014) · Chemical Reviews · doi:10.1021/cr400698c · Cited by 497 · see citing works
Pennington, K. L., Ty, C., Torres, M. P., & Andersen, J. (2018) · Oncogene · doi:10.1038/s41388-018-0348-3 · Cited by 365 · see citing works
Readout of Epigenetic Modifications
Patel, D. J., & Wang, Z. (2013) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-072711-165700 · Cited by 316 · see citing works
Oncogenic protein interfaces: small molecules, big challenges
Nero, T. L., Morton, C. J., Holien, J. K., Wielens, J., & Parker, M. W. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3690 · Cited by 312 · see citing works
Modulators of 14-3-3 Protein–Protein Interactions
Stevers, L. M., Sijbesma, E., Botta, M., MacKintosh, C., Obšil, T., Landrieu, I., Cau, Y., Wilson, A. J., Karawajczyk, A., Eickhoff, J., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00574 · Cited by 289 · see citing works
The role of the 14-3-3 protein family in health, disease, and drug development
Aghazadeh, Y., & Papadopoulos, V. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.09.012 · Cited by 252 · see citing works
Molecular tweezers modulate 14-3-3 protein–protein interactions
Bier, D., Rose, R., Bravo‐Rodriguez, K., Bartel, M., Ramírez‐Anguita, J. M., Dutt, S., Wilch, C., Klärner, F., Sánchez‐García, E., Schrader, T. H., et al. (2013) · Nature Chemistry · doi:10.1038/nchem.1570 · Cited by 195 · see citing works
14-3-3 proteins as potential therapeutic targets
Zhao, J., Meyerkord, C. L., Du, Y., Khuri, F. R., & Fu, H. (2011) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2011.09.012 · Cited by 163 · see citing works
Self-citationStructural insights into the functional roles of 14-3-3 proteins
Obšilová, V., & Obšil, T. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.1016071 · Cited by 129 · see citing works
Site-Directed Fragment-Based Screening for the Discovery of Protein–Protein Interaction Stabilizers
Sijbesma, E., Hallenbeck, K. K., Leysen, S., de Vink, P. J., Skóra, L., Jahnke, W., Brunsveld, L., Arkin, M. R., & Ottmann, C. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.8b11658 · Cited by 110 · see citing works
Kozakov, D., Hall, D. R., Napoleon, R. L., Yueh, C., Whitty, A., & Vajda, S. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00586 · Cited by 111 · see citing works
de Vink, P. J., Briels, J. M., Schrader, T. H., Milroy, L. ‐., Brunsveld, L., & Ottmann, C. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201701807 · Cited by 90 · see citing works
Stabilization and Inhibition of Protein–Protein Interactions: The 14-3-3 Case Study
Milroy, L.-G., Brunsveld, L., & Ottmann, C. (2013) · ACS Chemical Biology · doi:10.1021/cb300599t · Cited by 88 · see citing works
Structure, Function, Involvement in Diseases and Targeting of 14-3-3 Proteins: An Update
Cau, Y., Valensin, D., Mori, M., Draghi, S., & Botta, M. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666170426095015 · Cited by 87 · see citing works
Synergistic Binding of the Phosphorylated S233- and S259-Binding Sites of C-RAF to One 14-3-3ζ Dimer
Molzan, M., & Ottmann, C. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2012.08.009 · Cited by 87 · see citing works
G protein-coupled adenosine (P1) and P2Y receptors: ligand design and receptor interactions
Jacobson, K. A., Balasubramanian, R., Deflorian, F., & Gao, Z. (2012) · Purinergic Signalling · doi:10.1007/s11302-012-9294-7 · Cited by 86 · see citing works
Tyrosine and tryptophan hydroxylases as therapeutic targets in human disease
Waløen, K., Kleppe, R., Martı́nez, A., & Haavik, J. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1272581 · Cited by 85 · see citing works
Shen, M., Wei, Y., Kim, H., Wan, L., Jiang, Y., Hang, X., Raba, M., Remiszewski, S., Rowicki, M., Wu, C.-G., et al. (2021) · Nature Cancer · doi:10.1038/s43018-021-00279-5 · Cited by 81 · see citing works
Self-citationInvolvement of 14‐3‐3 in tubulin instability and impaired axon development is mediated by Tau
Joo, Y., Schumacher, B., Landrieu, I., Bartel, M., Smet‐Nocca, C., Jang, A., Choi, H. S., Jeon, N. L., Chang, K., Kim, H., et al. (2015) · The FASEB Journal · doi:10.1096/fj.14-265009 · Cited by 80 · see citing works
Small molecule modulators of protein-protein interactions: selected case studies
Aeluri, M., Chamakuri, S., Dasari, B., Guduru, S. K. R., Jimmidi, R., Jogula, S., & Arya, P. (2014) · Chemical Reviews · doi:10.1021/cr4004049 · Cited by 79 · see citing works
14-3-3 Proteins: Novel Pharmacological Targets in Neurodegenerative Diseases
Pair, F. S., & Yacoubian, T. A. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.01.001 · Cited by 74 · see citing works
S6K2: The Neglected S6 Kinase Family Member
Pardo, O. E., & Seckl, M. J. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00191 · Cited by 71 · see citing works
Sijbesma, E., Visser, E., Plitzko, K., Thiel, P., Milroy, L.-G., Kaiser, M., Brunsveld, L., & Ottmann, C. (2020) · Nature Communications · doi:10.1038/s41467-020-17741-0 · Cited by 72 · see citing works
Order by disorder in plant signaling
Kragelund, B. B., Jensen, M. K., & Skriver, K. (2012) · Trends in Plant Science · doi:10.1016/j.tplants.2012.06.010 · Cited by 71 · see citing works
Li, H., Peyrollier, K., Kilic, G., & Brakebusch, C. (2013) · BioFactors · doi:10.1002/biof.1155 · Cited by 61 · see citing works
Structural interface between LRRK2 and 14-3-3 protein
Stevers, L. M., de Vries, R. M. J. M., Doveston, R. G., Milroy, L. ‐., Brunsveld, L., & Ottmann, C. (2017) · Biochemical Journal · doi:10.1042/bcj20161078 · Cited by 59 · see citing works
Direct and Propagated Effects of Small Molecules on Protein–Protein Interaction Networks
Cesa, L. C., Mapp, A. K., & Gestwicki, J. E. (2015) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2015.00119 · Cited by 58 · see citing works
An Optimised Small‐Molecule Stabiliser of the 14‐3‐3–PMA2 Protein–Protein Interaction
Richter, A. M., Rose, R., Hedberg, C., Waldmann, H., & Ottmann, C. (2012) · Chemistry - A European Journal · doi:10.1002/chem.201103761 · Cited by 56 · see citing works
The overexpression of 14‐3‐3ζ and Hsp27 promotes non–small cell lung cancer progression
Zhao, G., Ding, J., Gu, J., Lu, C., Lin, Z., Guo, J., & Ge, D. (2013) · Cancer · doi:10.1002/cncr.28452 · Cited by 52 · see citing works
Thymoquinone Blocks pSer/pThr Recognition by Plk1 Polo-Box Domain As a Phosphate Mimic
Yin, Z., Song, Y., & Rehse, P. H. (2012) · ACS Chemical Biology · doi:10.1021/cb3004379 · Cited by 50 · see citing works
Protein–Protein Interactions as Drug Targets
Skwarczynska, M., & Ottmann, C. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.138 · Cited by 50 · see citing works
Thiel, P., Röglin, L., Meissner, N., Hennig, S., Kohlbacher, O., & Ottmann, C. (2013) · Chemical Communications · doi:10.1039/c3cc44612c · Cited by 47 · see citing works
Small-molecule modulators of 14-3-3 protein–protein interactions
Ottmann, C. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.11.028 · Cited by 46 · see citing works
Identification of Two Secondary Ligand Binding Sites in 14-3-3 Proteins Using Fragment Screening
Sijbesma, E., Skóra, L., Leysen, S., Brunsveld, L., Koch, U., Nußbaumer, P., Jahnke, W., & Ottmann, C. (2017) · Biochemistry · doi:10.1021/acs.biochem.7b00153 · Cited by 46 · see citing works
Targeting 14-3-3zeta in cancer therapy
Yang, X., Cao, W., Zhang, L., Zhang, W., Zhang, X., & Lin, H. (2011) · Cancer Gene Therapy · doi:10.1038/cgt.2011.85 · Cited by 45 · see citing works
Self-citationIntracellular Generation of a Diterpene-Peptide Conjugate that Inhibits 14-3-3-Mediated Interactions
Parvatkar, P. T., Kato, N., Uesugi, M., Sato, S., & Ohkanda, J. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b09817 · Cited by 42 · see citing works
Goc, A., Abdalla, M., Al‐Azayzih, A., & Somanath, P. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040594 · Cited by 41 · see citing works
Destabilisation of dimeric 14-3-3 proteins as a novel approach to anti-cancer therapeutics
Woodcock, J. M., Coolen, C., Goodwin, K. L., Baek, D. J., Bittman, R., Samuel, M. S., Pitson, S. M., & Lopez, A. F. (2015) · Oncotarget · doi:10.18632/oncotarget.3995 · Cited by 39 · see citing works
Structural insights of the MLF1/14‐3‐3 interaction
Molzan, M., Weyand, M., Rose, R., & Ottmann, C. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08445.x · Cited by 38 · see citing works
Small molecules that target phosphorylation dependent protein–protein interaction
Watanabe, N., & Osada, H. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.03.023 · Cited by 37 · see citing works
Hartman, A. M., Elgaher, W. A. M., Hertrich, N., Andrei, S. A., Ottmann, C., & Hirsch, A. K. H. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00541 · Cited by 36 · see citing works
Hartman, A. M., & Hirsch, A. K. H. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.04.058 · Cited by 35 · see citing works
Du, Y., Fu, R. W., Lou, B., Zhao, J., Qui, M., Khuri, F. R., & Fu, H. (2013) · Assay and Drug Development Technologies · doi:10.1089/adt.2013.507 · Cited by 34 · see citing works
Self-citationChemical ligation of epoxide-containing fusicoccins and peptide fragments guided by 14-3-3 protein
Maki, T., Kawamura, A., Kato, N., & Ohkanda, J. (2012) · Molecular BioSystems · doi:10.1039/c2mb25388g · Cited by 31 · see citing works
Small molecules modulation of 14-3-3 protein–protein interactions
Mori, M., Vignaroli, G., & Botta, M. (2012) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2012.10.001 · Cited by 30 · see citing works
Influence of Spacer–Receptor Interactions on the Stability of Bivalent Ligand–Receptor Complexes
Numata, J., Juneja, A., Diestler, D. J., & Knapp, E. (2012) · The Journal of Physical Chemistry B · doi:10.1021/jp211383s · Cited by 29 · see citing works
Scaffold Repurposing of Old Drugs Towards New Cancer Drug Discovery
Chen, H., Wu, J., Gao, Y., Chen, H., & Zhou, J. (2016) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026616666160216155556 · Cited by 29 · see citing works
Small Molecules, Peptides and Natural Products: Getting a Grip on 14-3-3 Protein–Protein Modulation
Bartel, M., Schäfer, A., Stevers, L. M., & Ottmann, C. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.14.47 · Cited by 28 · see citing works
Molecular glues of the regulatory ChREBP/14-3-3 complex protect beta cells from glucolipotoxicity
Katz, L. S., Visser, E. J., Plitzko, K., Pennings, M. A. M., Cossar, P. J., Tse, I., Kaiser, M., Brunsveld, L., Ottmann, C., & Scott, D. K. (2025) · Nature Communications · doi:10.1038/s41467-025-57241-7 · Cited by 28 · see citing works
de Vink, P. J., Briels, J. M., Schrader, T. H., Milroy, L. ‐., Brunsveld, L., & Ottmann, C. (2017) · Angewandte Chemie · doi:10.1002/ange.201701807 · Cited by 28 · see citing works
The Multifarious Role of 14-3-3 Family of Proteins in Viral Replication
Nathan, K. G., & Lal, S. K. (2020) · Viruses · doi:10.3390/v12040436 · Cited by 27 · see citing works
Fusicoccin: A Chemical Modulator for 14-3-3 Proteins
Ohkanda, J. (2020) · Chemistry Letters · doi:10.1246/cl.200670 · Cited by 25 · see citing works
Haladová, K., Mrázek, H., Ječmen, T., Halada, P., Man, P., Novák, P., Chmelík, J., Obšil, T., & Šulc, M. (2012) · Journal of Structural Biology · doi:10.1016/j.jsb.2012.04.016 · Cited by 25 · see citing works
Scaffold Functions of 14-3-3 Adaptors in B Cell Immunoglobulin Class Switch DNA Recombination
Lam, T., Thomas, L. M. B., White, C. A., Li, G., Pone, E. J., Xu, Z., & Casali, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080414 · Cited by 25 · see citing works
X-ray Structures of Target–Ligand Complexes Containing Compounds with Assay Interference Potential
Gilberg, E., Gütschow, M., & Bajorath, J. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01780 · Cited by 23 · see citing works
Ishikawa, F., Miyamoto, K., Konno, S., Kasai, S., & Kakeya, H. (2015) · ACS Chemical Biology · doi:10.1021/acschembio.5b00595 · Cited by 22 · see citing works
Versatility of 14-3-3 proteins and their roles in bone and joint-related diseases
Zhou, R., Hu, W., Ma, P. X., & Liu, C.-J. (2024) · Bone Research · doi:10.1038/s41413-024-00370-4 · Cited by 22 · see citing works
Shi, M., & Xu, D. (2019) · Frontiers in Chemistry · doi:10.3389/fchem.2019.00237 · Cited by 21 · see citing works
Raf‐interactome in tuning the complexity and diversity of Raf function
An, S., Yang, Y., Ward, R. J., Liu, Y., Guo, X., & Xu, T. (2014) · FEBS Journal · doi:10.1111/febs.13113 · Cited by 20 · see citing works
Ehlers, M., Grad, J., Mittal, S., Bier, D., Mertel, M., Ohl, L., Bartel, M., Briels, J. M., Heimann, M., Ottmann, C., et al. (2017) · ChemBioChem · doi:10.1002/cbic.201700588 · Cited by 20 · see citing works
Hu, G., Cao, Z., Xu, S., Wang, W., & Wang, J. (2015) · Scientific Reports · doi:10.1038/srep16481 · Cited by 19 · see citing works
Covalent attachment of pyridoxal-phosphate derivatives to 14-3-3 proteins
Röglin, L., Thiel, P., Kohlbacher, O., & Ottmann, C. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1116592109 · Cited by 19 · see citing works
Low, Z. Y., Yip, A. J. W., Chan, A. M. L., & Choo, W. S. (2024) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30624 · Cited by 19 · see citing works
Varlı, M., Bhosle, S. R., Kim, E., Yang, Y., Taş, İ., Zhou, R., Pulat, S., Gamage, C. D. B., Park, S., Ha, H., et al. (2024) · JACS Au · doi:10.1021/jacsau.3c00774 · Cited by 18 · see citing works
A pan-respiratory antiviral chemotype targeting a transient host multi-protein complex
Michon, M., Müller‐Schiffmann, A., Lingappa, A. F., Yu, S. F., Du, L., Deiter, F., Broce, S., Mallesh, S., Crabtree, J. M., Lingappa, U. F., et al. (2024) · Open Biology · doi:10.1098/rsob.230363 · Cited by 15 · see citing works
Self-citation14-3-3γ affects mTOR pathway and regulates lactogenesis in dairy cow mammary epithelial cells
Khudhair, N., Luo, C., Khalid, A., Zhang, L., Zhang, S., Ao, J., Li, Q., & Gao, X. (2015) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-015-9879-x · Cited by 13 · see citing works
Self-citationBabula, J. J., & Liu, J. (2015) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2015.09.002 · Cited by 12 · see citing works
Panda, S. P., Kesharwani, A., Singh, B., Marisetti, A. L., Chaitanya, M., Dahiya, S., Ponnusankar, S., Kumar, S., Singh, M., Shakya, P. K., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102572 · Cited by 11 · see citing works
Ptáčková, R., Ječmen, T., Novák, P., Hudeček, J., Stiborová, M., & Šulc, M. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15069224 · Cited by 11 · see citing works
Disruption of Protein-Protein Interfaces
Mangani, S. (2013) · Springer eBooks · doi:10.1007/978-3-642-37999-4 · Cited by 11 · see citing works
Yilmaz, E., Bier, D., Guillory, X., Briels, J. M., Ruiz‐Blanco, Y. B., Sánchez‐García, E., Ottmann, C., & Kaiser, M. (2018) · Chemistry - A European Journal · doi:10.1002/chem.201801074 · Cited by 11 · see citing works
Masuda, R., Kawasaki, Y., Igawa, K., Manabe, Y., Fujii, H., Kato, N., Tomooka, K., & Ohkanda, J. (2020) · Chemistry - An Asian Journal · doi:10.1002/asia.202000042 · Cited by 11 · see citing works
Song, K., Nho, C. W., Ha, I. J., & Kim, Y. S. (2020) · Journal of Natural Products · doi:10.1021/acs.jnatprod.0c00043 · Cited by 10 · see citing works
Chakraborty, G., & Patra, N. (2024) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.4c01743 · Cited by 9 · see citing works
Kleppe, R., Ghorbani, S., Martı́nez, A., & Haavik, J. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.11.012 · Cited by 9 · see citing works
Plaza-Garrido, M., Salinas-García, M. C., Martínez, J. C., & Cámara-Artigas, A. (2020) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-020-01785-0 · Cited by 7 · see citing works
Small molecule microarray screening methodology based on surface plasmon resonance imaging
Singh, V., Singh, K., Nand, A., Dai, H., Wang, J., Zhang, L., Merino, A., & Zhu, J. (2015) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2014.12.020 · Cited by 7 · see citing works
Self-citation[Analysis of differentially expressed proteome in urine from non-small cell lung cancer patients].
Chen, Z., Liu, J., Lin, L., Xie, H., Zhang, W., Zhang, H., & Wang, G. (2015) · Europe PMC (PubMed Central) · doi:10.3779/j.issn.1009-3419.2015.03.03 · Cited by 7 · see citing works
Zhao, J., Jiang, H., Zhao, K., Liu, T., Zhang, Q., Zhao, Z., Wang, J., You, Q., Lu, M., & Jiang, Z. (2025) · Chemical Science · doi:10.1039/d5sc04324g · Cited by 5 · see citing works
Self-citationOptimizing Phosphopeptide Structures That Target 14-3-3ε in Cutaneous Squamous Cell Carcinoma
Kamayirese, S., Maity, S., Dieckman, L. M., Hansen, L. A., & Lovas, S. (2024) · ACS Omega · doi:10.1021/acsomega.3c07740 · Cited by 5 · see citing works
The Effect of 5'-Adenylic Acid on Hepatic Proteome of Mice Radiated by 60Co γ-ray
Cheng, C., Zhao, H., Wang, Z., Lu, W., Wang, L., Wang, R., & Yao, L. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms15010186 · Cited by 4 · see citing works
Protein–Protein Interaction Inhibitors in Cancer
Hardcastle, I. R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12392-3 · Cited by 4 · see citing works
The International Chemical Biology Community Synthesizes a New Society
Johns, M. A. (2012) · ACS Chemical Biology · doi:10.1021/cb200507f · Cited by 4 · see citing works
Small-molecule Modulators of Protein–Protein Interactions: Focus on 14-3-3 PPIs
Iralde-Lorente, L., Botta, M., & Ottmann, C. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781788016544-00249 · Cited by 3 · see citing works
Discovery of a Plant 14‐3‐3 Inhibitor Possessing Isoform Selectivity and In Planta Activity
Nishiyama, K., Aihara, Y., Suzuki, T., Takahashi, K. U., Kinoshita, T., Dohmae, N., Sato, A., & Hagihara, S. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202400218 · Cited by 3 · see citing works
PAR-5is a PARty hub in the germline
Aristizábal-Corrales, D., Schwartz, S., & Cerón, J. (2013) · Worm · doi:10.4161/worm.21834 · Cited by 3 · see citing works
Subnetwork estimation for spatial autoregressive models in large-scale networks
Li, X., Wang, F., Lan, W., & Wang, H. (2023) · Electronic Journal of Statistics · doi:10.1214/23-ejs2139 · Cited by 2 · see citing works
Nazir, A. (2024) · Protein and Peptide Letters · doi:10.2174/0109298665330728241025082011 · Cited by 2 · see citing works
14-3-3γ affects eIF5 to regulate β-casein synthesis in bovine mammary epithelial cells
Yu, C., Luo, C., Gu, X., Zang, Y., Qu, B., Khudhair, N., Li, Q., & Gao, X. (2016) · Canadian Journal of Animal Science · doi:10.1139/cjas-2016-0038 · Cited by 2 · see citing works
Ng, Y., Sorvina, A., Bader, C. A., Weiland, F., Lopez, A. F., Hoffmann, P., Shandala, T., & Brooks, D. A. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b01032 · Cited by 2 · see citing works
Upadhyay, A. K., Horton, J. R., Du, Y., Bai, Y., Cheng, X., & Fu, H. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203341109 · Cited by 2 · see citing works
Self-citationChakraborty, G., Chaudhary, A., & Patra, N. (2025) · Advanced Theory and Simulations · doi:10.1002/adts.202501455 · Cited by 1 · see citing works
Ponterini, G. (2013) · Springer eBooks · doi:10.1007/978-3-642-37999-4_6 · Cited by 1 · see citing works
Zhou, X., Shi, M., Wang, X., & Xu, D. (2022) · Frontiers in Chemistry · doi:10.3389/fchem.2022.921695 · Cited by 1 · see citing works
Small-Molecule Inhibitors of Protein–Protein Interactions as Therapeutics
Poluri, K. M., Gulati, K., Tripathi, D. K., & Nagar, N. (2023) · Springer eBooks · doi:10.1007/978-981-99-2423-3_7 · Cited by 1 · see citing works
Discovery of a Plant 14‐3‐3 Inhibitor Possessing Isoform Selectivity and In Planta Activity
Nishiyama, K., Aihara, Y., Suzuki, T., Takahashi, K. U., Kinoshita, T., Dohmae, N., Sato, A., & Hagihara, S. (2024) · Angewandte Chemie · doi:10.1002/ange.202400218 · Cited by 1 · see citing works
High Throughput Screening Methods for PPI Inhibitor Discovery
Doyle, S. P., Mo, X., Qian, K., Cicka, D., Niu, Q., & Fu, H. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781788016544-00049 · Cited by 1 · see citing works
Self-citationThe design and synthesis of peptidomimetic serine-based prodrugs as 14-3-3 inhibitors
Jones, E. D. (2013) · Purdue e-Pubs (Purdue University System)
Kinetic characterization of VopT, a mono-ADP-ribosyltransferase toxin from Vibrio parahaemolyticus
Poole, A. (2016) · The Atrium (University of Guelph)
- Authors
- Zhao, J., Du, Y., Horton, J. R., Upadhyay, A. K., Lou, B., Bai, Y., Zhang, X., Du, L., Li, M., Wang, B., Zhang, L., Barbieri, J. T., Khuri, F. R., Cheng, X., & Fu, H.
- Affiliations
- Air Force Medical University (CN)
- Emory University (US)
- Biochemistry; and
- Departments of Pharmacology;
- Department of Chemistry, Georgia State University, Atlanta, GA 30302;
- Georgia State University (US)
- Chinese Academy of Sciences (CN)
- Medical College of Wisconsin (US)
- Hematology and Medical Oncology;
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2011-09-09
- Volume
- 108
- Issue
- 39
- Pages
- 16212-16216
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3182712
- OpenAlex
- W2156331971
- Cited by
- 105
- References
- 38
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 10 · 2023: 2 · 2022: 2 · 2021: 2 · 2020: 10 · 2019: 3 · 2018: 3 · 2017: 9 · 2016: 7 · 2015: 13 · 2014: 6 · 2013: 15 · 2012: 15
- FWCI
- 5.06
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Emory University
- School of Medicine, Emory University
- National Cancer Institute (P01CA116676)
- National Institute of General Medical Sciences (GM092035, GM068680, RC1GM092035, R01GM068680)
- National Institute of Allergy and Infectious Diseases (AI-030162, R01AI030162)
- Argonne National Laboratory
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › 14-3-3 protein interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Keywords
- 14-3-3 proteins, protein-protein interaction inhibitors, small molecule inhibitors, Raf-1, PRAS40, cancer therapy
- MeSH terms
- Animals, Chlorocebus aethiops, Enzyme-Linked Immunosorbent Assay, Fluorescence Polarization, Models, Molecular, Protein Binding, Protein Conformation, Crystallography, X-Ray, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, COS Cells, 14-3-3 Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review